Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Officer
Latest Insider Transactions
Showing 10 of 15 transactions (past 365 days)
| 2026-05-05 | 2026-05-04 | ACAD Acadia Pharmaceuticals Inc | CFO | Sale | 3,506 | $21.79 | $76,396 |
| 2026-05-05 | 2026-05-01 | ACAD Acadia Pharmaceuticals Inc | CFO | Exercise Conversion | 6,815 | $0.00 | $0 |
| 2026-04-07 | 2026-04-07 | ACAD Acadia Pharmaceuticals Inc | CFO | Sale | 2,709 | $22.20 | $60,140 |
| 2026-04-07 | 2026-04-05 | ACAD Acadia Pharmaceuticals Inc | CFO | Exercise Conversion | 5,276 | $0.00 | $0 |
| 2026-03-27 | 2026-03-26 | ACAD Acadia Pharmaceuticals Inc | CFO | Sale | 3,171 | $21.65 | $68,652 |
| 2026-03-27 | 2026-03-26 | ACAD Acadia Pharmaceuticals Inc | CFO | Sale | 37 | $21.72 | $804 |
| 2026-03-27 | 2026-03-25 | ACAD Acadia Pharmaceuticals Inc | CFO | Exercise Conversion | 6,178 | $0.00 | $0 |
| 2026-03-27 | 2026-03-25 | ACAD Acadia Pharmaceuticals Inc | CFO | Sale | 4,177 | $21.47 | $89,680 |
| 2026-03-27 | 2026-03-24 | ACAD Acadia Pharmaceuticals Inc | CFO | Exercise Conversion | 8,138 | $0.00 | $0 |
| 2026-03-10 | 2026-03-06 | ACAD Acadia Pharmaceuticals Inc | CFO | Award | 90,691 | $22.16 | $2,009,713 |
ACAD
CFO
Exercise Conversion
$0
6,815 shares @ $0.00
Filed 2026-05-05Trade 2026-05-01
Acadia Pharmaceuticals IncACAD
CFO
Exercise Conversion
$0
5,276 shares @ $0.00
Filed 2026-04-07Trade 2026-04-05
Acadia Pharmaceuticals IncACAD
CFO
Exercise Conversion
$0
6,178 shares @ $0.00
Filed 2026-03-27Trade 2026-03-25
Acadia Pharmaceuticals IncACAD
CFO
Exercise Conversion
$0
8,138 shares @ $0.00
Filed 2026-03-27Trade 2026-03-24
Acadia Pharmaceuticals IncWant to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.